Ruxolitinib Interactions
There are 512 drugs known to interact with ruxolitinib, along with 12 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 137 are major, 314 are moderate, and 61 are minor.
- View all 512 medications that may interact with ruxolitinib
- View ruxolitinib alcohol/food interactions (2)
- View ruxolitinib disease interactions (12)
Most frequently checked interactions
View interaction reports for ruxolitinib and the medicines listed below.
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Ativan (lorazepam)
- Celexa (citalopram)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Concerta (methylphenidate)
- CoQ10 (ubiquinone)
- Cosopt (dorzolamide / timolol ophthalmic)
- Coumadin (warfarin)
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- Focalin (dexmethylphenidate)
- Heparin Sodium (heparin)
- Humira (adalimumab)
- Lumigan (bimatoprost ophthalmic)
- Metoprolol Tartrate (metoprolol)
- Oramorph SR (morphine)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Singulair (montelukast)
- Sotalol Hydrochloride AF (sotalol)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Ruxolitinib alcohol/food interactions
There are 2 alcohol/food interactions with ruxolitinib.
Ruxolitinib disease interactions
There are 12 disease interactions with ruxolitinib which include:
- cardiovascular risk
- malignancy
- thrombosis
- lung toxicity
- cytopenia
- hepatic impairment
- Hepatitis B
- infections
- lipid elevations
- PML
- renal impairment
- tuberculosis
Report options
More about ruxolitinib
- ruxolitinib consumer information
- Compare alternatives
- Reviews (43)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Besremi
Besremi (ropeginterferon alfa-2b-njft) is used for the treatment of adults with polycythemia vera ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
